References
- Wasserman AM. Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2011;84(11):1245–1252.
- Murrell DF, Marinovic B, Caux F, et al. Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. J Am Acad Dermatol. 2015;72(1):168–174.
- Olsen KE, Holland EJ. The association between ocular cicatricial pemphigoid and rheumatoid arthritis. Cornea. 1998;17(5):504–507.
- Foster CS. Cicatricial pemphigoid. Trans Am Ophthalmol Soc. 1986;84:527–663.
- Spigel GT, Winkelmann RK. Cicatricial pemphigoid and rheumatoid arthritis. Arch Dermatol. 1978;114(3):415–417.
- Shuttleworth D, Graham-Brown RA, Hutchinson PE, et al. Cicatricial pemphigoid in D-penicillamine treated patients with rheumatoid arthritis-a report of three cases. Clin Exp Dermatol. 1985;10(4):392–397.
- Wu D, Zhang LM, Jiang Y. Cicatricial pemphigoid in accompany with rheumatoid arthritis: a case report. Chin Med Sci J. 2010;25(3):182–184.
- Peyrí J, Servitje O, Ribera M, et al. Cicatricial pemphigoid in a patient with rheumatoid arthritis treated with D-penicillamine. J Am Acad Dermatol. 1986;14(4):681.
- Cytryn E, Laduron JC, Colebunders R, et al. Oesophageal stenosis caused by benign mucous membrane pemphigoïd in a patient with an inactive rheumatoïd arthritis. Rofo. 1985;142(4):469–470.
- Gibert M, Balandraud N, Touinssi M, et al. Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect. Hum Immunol. 2003;64(10):930–935.
- Tavakolpour S, Alesaeidi S, Darvishi M, et al. A comprehensive review of rituximab therapy in rheumatoid arthritis patients. Clin Rheumatol. 2019;38(11):2977–2994.
- Zaltas MM, Ahmed R, Foster CS. Association of HLA-DR4 with ocular cicatricial pemphigoid. Curr Eye Res. 1989;8(2):189–193.
- Le Roux-Villet C, Prost-Squarcioni C, Alexandre M, et al. Rituximab for patients with refractory mucous membrane pemphigoid. Arch Dermatol. 2011;147(7):843–849.
- Boussemart L, Jacobelli S, Batteux F, et al. Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports. Dermatology. 2010;221(3):201–205.
- Bordignon M, Belloni-Fortina A, Pigozzi B, et al. Bullous pemphigoid during long-term TNF-alpha blocker therapy. Dermatology. 2009;219(4):357–358.